tirzepatide cv outcomes In patients with type 2 diabetes and atherosclerotic cardiovascular disease, was noninferior to dulaglutide with respect to major cardiovascular events. ⁣, ⁣, Read the full SURPASS-CVOT Tirzepatide for Heart Failure with

September 15, 2025: Study Finds Over Half of New Rybelsus Users Stop the Drug Within a Year A new Danish study found that more than half of new Rybelsus patients stopped using the semaglutide injections within a year after starting them

Semaglutide functions by mimicking the action of the GLP-1 hormone, crucial for appetite regulation and glucose metabolism

On this episode of Monday Health Minutes, Melanie Shafer talks with Valley Health family physician Dr

However, GLP-1 medications may still be covered for secondary medical indications

Methionine restriction restores a younger metabolic phenotype in adult mice with alterations in fibroblast growth factor 21

This is particularly frustrating because the 10-week billing cycle means a 6-week shipping delay consumes more than half of the paid subscription period before the medication is even in hand